Beryl Drugs Ltd. benchmarking: Perfomance to industry peers

Financial

	Beryl Drugs	Parmax Pharma	Link Pharma Chem
Operational Metrics
Financials
5 yr Average ROE	3.64 %	-1068.03 %	1.59 %
5yr average Equity Multiplier	2.12	29.23	1.99
5yr Average Asset Turnover Ratio	1.19	1.05	1.33
5yr Avg Net Profit Margin	1.13 %	-11.29 %	-0.06 %
Price to Book	1.27	0.0	0.99
P/E	49.39	0.0	0.0
5yr Avg Cash Conversion Cycle	-589.78 Days	-92.25 Days	82.44 Days
Inventory Days	36.09 Days	69.37 Days	64.96 Days
Days Receivable	112.55 Days	20.01 Days	72.97 Days
Days Payable	964.25 Days	296.94 Days	84.21 Days
5yr Average Interest Coverage Ratio	1.91	-0.77	2.35
5yr Avg ROCE	7.2 %	-14.3 %	5.35 %
5yr Avg Operating Profit Margin	6.72 %	2.43 %	3.76 %
5 yr average Debt to Equity	0.59	10.96	0.49
5yr CAGR Net Profit	19.3 %	n/a	n/a
5yr Average Return on Assets	1.98 %	-9.05 %	0.6 %
Shareholdings
Promoter Holding	26.38 %	30.8 %	51.49 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	1.46 %	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0